Preventing Fraud Is A Task For Scientists, Not Congress

For the last five months, representatives of higher education associations and scientific societies have been working out guidelines on research fraud and misconduct The goal is to help universities to construct a process for dealing with any charges of impropriety made against members of faculty or staff. Universities must, by law, have such a process or forfeit eligibility for National Institutes of Health funding, and there are good reasons to believe that at least some institutions can, w

Written byRobert Rosenzweig Rosenzweig
| 5 min read

Register for free to listen to this article
Listen with Speechify
0:00
5:00
Share

For the last five months, representatives of higher education associations and scientific societies have been working out guidelines on research fraud and misconduct The goal is to help universities to construct a process for dealing with any charges of impropriety made against members of faculty or staff. Universities must, by law, have such a process or forfeit eligibility for National Institutes of Health funding, and there are good reasons to believe that at least some institutions can, with help, improve their ability to handle these difficult cases.

This is an important undertaking. Unless universities do, and are seen to do, a better job of dealing with fraud and misconduct than has been the norm in recent years, they run the risk of the government stepping in to take charge. In fact, the Congress almost passed a proposal before it adjourned in October that would have been a disaster for science ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies